ASSOCIATION BETWEEN POLYMORPHISMS OF THE DNA REPAIR GENE RAD 51 AND OVARIAN CANCER

1Department of Fetal-Maternal Medicine and Gynecology, Institute of Polish Mother’s Memorial Hospital, Lodz, Poland 2Regional Hospital in Lodz, Poland 3Department of Obstetrics and Gynaecology, Regional Hospital in Kalisz, Poland 4Department of Mother’s and Child’s Health, Poznan University of Medical Sciences, Poznan, Poland 5Clinic of Gynaecological Surgery, Poznan University of Medical Sciences, Poznan, Poland 6Department of Clinical Psychology, Poznan University of Medical Sciences, Poland 7University of Computer Sciences and Skills, Lodz, Poland 8Department of Medical Education, Poznan University of Medical Sciences, Poznan, Poland

[1]  M. Bryś,et al.  RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women. , 2013, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[2]  M. Rydzanicz,et al.  Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking- and drinking-related laryngeal cancer in a Polish population , 2012, Archives of medical science : AMS.

[3]  A. Dziki,et al.  RAD51 gene polymorphisms and sporadic colorectal cancer risk in Poland. , 2012, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[4]  A. Filip,et al.  Biological and clinical significance of BRCA2 , 2011 .

[5]  A. Mannermaa,et al.  Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility , 2011, Breast Cancer Research and Treatment.

[6]  Nina Ditsch,et al.  Hereditary breast and ovarian cancer: new genes, new treatments, new concepts. , 2011, Deutsches Arzteblatt international.

[7]  I. Majsterek,et al.  Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population. , 2010, Experimental and molecular pathology.

[8]  J. Błasiak,et al.  Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer—a case control study , 2010, Molecular Biology Reports.

[9]  Nandita Mitra,et al.  Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. , 2009, Cancer research.

[10]  F. Couch,et al.  RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. , 2007, American journal of human genetics.

[11]  R. Scott,et al.  The RAD51 135 G>C Polymorphism Modifies Breast Cancer and Ovarian Cancer Risk in Polish BRCA1 Mutation Carriers , 2007, Cancer Epidemiology Biomarkers & Prevention.

[12]  M. Spitz,et al.  172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. , 2006, Carcinogenesis.

[13]  A. Whittemore,et al.  Polymorphisms in DNA repair genes and epithelial ovarian cancer risk , 2005, International journal of cancer.

[14]  I. Majsterek,et al.  Polymorphisms of the BRCA2 and RAD51 Genes in Breast Cancer , 2005, Breast Cancer Research and Treatment.

[15]  J. Thacker.  The RAD51 gene family, genetic instability and cancer. , 2005, Cancer letters.

[16]  John L Hopper,et al.  Double-Strand Break Repair Gene Polymorphisms and Risk of Breast or Ovarian Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[17]  T. Helleday.  Pathways for mitotic homologous recombination in mammalian cells. , 2003, Mutation research.

[18]  P. Hall,et al.  Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study , 2002, The Lancet.

[19]  S. Jackson,et al.  Sensing and repairing DNA double-strand breaks. , 2002, Carcinogenesis.

[20]  B. Modan,et al.  A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  J. Jiricny,et al.  Mismatch repair defects in cancer. , 2000, Current opinion in genetics & development.

[22]  P. Berg,et al.  Complex formation in yeast double-strand break repair: participation of Rad51, Rad52, Rad55, and Rad57 proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  H. Risch,et al.  Pelvic inflammatory disease and the risk of epithelial ovarian cancer. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  C. Oral,et al.  Spin Angular Momentum in Human Walking : Magnitude , Dimensionality and Distribution , 2006 .

[25]  M. Michalska,et al.  A single nucleotide polymorphism in the 5' untranslated region of RAD51 and ovarian cancer risk in Polish women. , 2012, European Journal of Gynaecological Oncology.

[26]  W. Shen,et al.  Same data sources, different pooled analysis result: the ongoing uncertainty in the subgroup analysis of RAD51 135G/C polymorphism and breast cancer risk , 2010, Breast Cancer Research and Treatment.

[27]  H. Stürzbecher,et al.  Characterisation of the promoter region of the human DNA-repair gene Rad51. , 2005, European journal of gynaecological oncology.